• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: IBSA FARMACEUTICI ITALIA SRL/IBSA PHARMA INC. GELSYN - 3 INJ 16.8/2 ML ; ACID, HYALURONIC, INTRAARTICULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

IBSA FARMACEUTICI ITALIA SRL/IBSA PHARMA INC. GELSYN - 3 INJ 16.8/2 ML ; ACID, HYALURONIC, INTRAARTICULAR Back to Search Results
Device Problem Insufficient Information (3190)
Patient Problem No Information (3190)
Event Date 10/11/2019
Event Type  Injury  
Event Description
Per (b)(6) using gelsyn 3 for both knee and shoulder is common practice for their office.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GELSYN - 3 INJ 16.8/2 ML
Type of Device
ACID, HYALURONIC, INTRAARTICULAR
Manufacturer (Section D)
IBSA FARMACEUTICI ITALIA SRL/IBSA PHARMA INC.
MDR Report Key9202999
MDR Text Key162886056
Report NumberMW5090444
Device Sequence Number1
Product Code MOZ
UDI-Device Identifier89130311101
UDI-Public89130311101
Combination Product (y/n)Y
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Type of Report Initial
Report Date 10/11/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/16/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator No Information
Was Device Available for Evaluation? No
Was Device Evaluated by Manufacturer? No Information
Type of Device Usage N
Patient Sequence Number1
-
-